首页> 美国卫生研究院文献>Children >Making Meaningful Improvements in Pharmacotherapy and Medication Management for Children and Youth—A Modest Proposal
【2h】

Making Meaningful Improvements in Pharmacotherapy and Medication Management for Children and Youth—A Modest Proposal

机译:在儿童和青少年的药物治疗和药物管理方面取得有意义的改进-适度的建议

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The Special Issue, “Development of a National Pediatric Pharmacotherapy Collaborative Practice Network,” has illuminated the vital global need for better care coordination and interprofessional collaboration in pharmacotherapy and medication management of children with medical complexity and special healthcare needs (CSHCN-CMC). From a population health perspective, we identified how coordination and outcomes might be improved from both practice and research perspectives, and what tools exist to assist clinical pharmacists and pediatricians to build more durable and sustainable comprehensive medication management practices around the world [ , ]. The work of the Professional Compounding Centers of America (PCCA) group [ ] and ‘GOLDILOKs’ (Genome and Ontogeny-Linked Dose Individualization and cLinical Optimization for KidS) Clinic [ ] illustrated personalized approaches to identifying, understanding, and responding to these patients’ unique drug therapy needs with evidence-based compounded formulations and genome-informed care planning. Ohio’s Partners for Kids Accountable Care Organization (ACO) provided a comprehensive, systems-based program for including clinical pharmacists to address inefficiencies in care coordination and delivery, especially in children with asthma and behavioral health needs [ ]. The development and inclusion of clinical pharmacists within maternal child health strategies of the Health Resources and Services Administration’s Pediatric Pulmonary Center in Arizona fostered improvements in community-based, family-centered healthcare for children with chronic respiratory diseases [ ]. Clearly, these approaches portend increased responsiveness to unmet drug-related needs at individual and system levels of analysis.
机译:特刊“国家小儿药物治疗协作实践网络的发展”阐明了在药物复杂性和特殊医疗需要的儿童的药物治疗和药物管理中,更好的护理协调和专业间合作的全球迫切需求(CSHCN-CMC)。从人群健康的角度,我们确定了如何从实践和研究的角度来改善协调和结果,以及存在哪些工具来协助临床药剂师和儿科医生在世界范围内建立更持久和可持续的综合药物管理实践[,]。美国专业复合中心(PCCA)组[]和“ GOLDILOKs”(基因组和个体发育相关的剂量个体化和针对KidS的临床优化)诊所的工作说明了识别,理解和应对这些患者的个性化方法。独特的药物治疗需求以及基于证据的复合制剂和基于基因组的护理计划。俄亥俄州的儿童负责人护理组织合作伙伴(ACO)提供了一个基于系统的综合计划,其中包括临床药剂师,以解决护理协调和交付效率低下的问题,尤其是对于有哮喘和行为健康需求的儿童[]。在亚利桑那州卫生资源和服务管理局的儿科肺病中心,孕产妇儿童健康策略中临床药师的发展和纳入,促进了社区基础,以家庭为中心的慢性呼吸系统疾病儿童的医疗保健的改善[]。显然,这些方法预示着在个人和系统分析水平上对未满足的与药物相关的需求的响应速度将加快。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号